AZB, Cyril Amarchand Mangaldas, Hogan Lovells act on Blue Jet Healthcare ₹800 crore QIP

Blue Jet Healthcare Limited has made a qualified institutions placement of 1,58,10,276 equity shares aggregating to ₹800 crore.

AZB & Partners advise Blu Jet Healthcare on this QIP.

Cyril Amarchand Mangaldas advised the placement agents, Motilal Oswal Investment Advisor Limited and ICICI Securities Limited, on this QIP.

The transaction was led by Ravi Dubey (Partner, Regional Co-Head - Capital Markets - West), and Oishika Dasgupta (Partner), with assistance from Abishek Sankar (Senior Associate), and Associates Akshita Dhawan, Nikshetaa Jain, Chinmay Jumde and Mitali Mangalam..

Hogan Lovells served as the international legal counsel for the placement agent.

The transaction was led by Biswajit Chatterjee (Head of the India Practice and Dubai Office Managing Partner).

Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredients company. They operate as an end-to-end Contract Development and Manufacturing Organization (CDMO) with a core focus on contrast media intermediates, high-intensity sweeteners, and niche active pharmaceutical ingredients (APIs). They are India's first manufacturer of saccharin.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.